These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 22322235)

  • 21. Neonatal hemochromatosis: a congenital alloimmune hepatitis.
    Whitington PF
    Semin Liver Dis; 2007 Aug; 27(3):243-50. PubMed ID: 17682971
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Resistance to hepcidin is conferred by hemochromatosis-associated mutations of ferroportin.
    Drakesmith H; Schimanski LM; Ormerod E; Merryweather-Clarke AT; Viprakasit V; Edwards JP; Sweetland E; Bastin JM; Cowley D; Chinthammitr Y; Robson KJ; Townsend AR
    Blood; 2005 Aug; 106(3):1092-7. PubMed ID: 15831700
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Non-HFE-related hereditary iron overload].
    Aguilar-Martinez P
    Presse Med; 2007 Sep; 36(9 Pt 2):1279-91. PubMed ID: 17540536
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Iron disorders of genetic origin: a changing world.
    Brissot P; Bardou-Jacquet E; Jouanolle AM; Loréal O
    Trends Mol Med; 2011 Dec; 17(12):707-13. PubMed ID: 21862411
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The iron driven pathway of hepcidin synthesis.
    Deugnier Y
    Gastroenterol Clin Biol; 2010; 34(6-7):351-4. PubMed ID: 20537480
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of hepatic transferrin, transferrin receptor and ferritin genes in human siderosis.
    Pietrangelo A; Rocchi E; Ferrari A; Ventura E; Cairo G
    Hepatology; 1991 Dec; 14(6):1083-9. PubMed ID: 1959858
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Non-HFE haemochromatosis.
    Wallace DF; Subramaniam VN
    World J Gastroenterol; 2007 Sep; 13(35):4690-8. PubMed ID: 17729390
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pathophysiology and genetics of classic HFE (type 1) hemochromatosis].
    Loréal O; Ropert M; Mosser A; Déhais V; Deugnier Y; David V; Brissot P; Jouanolle AM
    Presse Med; 2007 Sep; 36(9 Pt 2):1271-7. PubMed ID: 17521857
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relative contribution of iron genes, dysmetabolism and hepatitis C virus (HCV) in the pathogenesis of altered iron regulation in HCV chronic hepatitis.
    Valenti L; Pulixi EA; Arosio P; Cremonesi L; Biasiotto G; Dongiovanni P; Maggioni M; Fargion S; Fracanzani AL
    Haematologica; 2007 Aug; 92(8):1037-42. PubMed ID: 17640859
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Iron deficiency and iron overload.
    Jacobs A
    Crit Rev Oncol Hematol; 1985; 3(2):143-86. PubMed ID: 3896543
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepcidin and iron-related gene expression in subjects with Dysmetabolic Hepatic Iron Overload.
    Barisani D; Pelucchi S; Mariani R; Galimberti S; Trombini P; Fumagalli D; Meneveri R; Nemeth E; Ganz T; Piperno A
    J Hepatol; 2008 Jul; 49(1):123-33. PubMed ID: 18462824
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepcidin levels correlate to liver iron content, but not steatohepatitis, in non-alcoholic fatty liver disease.
    Marmur J; Beshara S; Eggertsen G; Onelöv L; Albiin N; Danielsson O; Hultcrantz R; Stål P
    BMC Gastroenterol; 2018 Jun; 18(1):78. PubMed ID: 29871592
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Differential liver siderosis diagnosis using quantitative iron determination in the biopsy specimen].
    Schmidt U; Preu E; Senf L
    Z Gastroenterol; 1993 Feb; 31 Suppl 2():64-6. PubMed ID: 7483718
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of hepcidin and iron-overload disease.
    Lee PL; Beutler E
    Annu Rev Pathol; 2009; 4():489-515. PubMed ID: 19400694
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Liver iron concentrations and urinary hepcidin in beta-thalassemia.
    Origa R; Galanello R; Ganz T; Giagu N; Maccioni L; Faa G; Nemeth E
    Haematologica; 2007 May; 92(5):583-8. PubMed ID: 17488680
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Molecular mechanisms of iron homeostasis].
    Beaumont C
    Med Sci (Paris); 2004 Jan; 20(1):68-72. PubMed ID: 14770366
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reversal of hemochromatosis by apotransferrin in non-transfused and transfused Hbbth3/+ (heterozygous B1/B2 globin gene deletion) mice.
    Gelderman MP; Baek JH; Yalamanoglu A; Puglia M; Vallelian F; Burla B; Vostal J; Schaer DJ; Buehler PW
    Haematologica; 2015 May; 100(5):611-22. PubMed ID: 25616571
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rapid development of hepatocellular siderosis after liver transplantation for neonatal hemochromatosis.
    Egawa H; Berquist W; Garcia-Kennedy R; Cox K; Knisely AS; Esquivel CO
    Transplantation; 1996 Nov; 62(10):1511-3. PubMed ID: 8958282
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Iron and the liver.
    Pietrangelo A
    Liver Int; 2016 Jan; 36 Suppl 1():116-23. PubMed ID: 26725908
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytomegalovirus infection, fetal liver disease, and neonatal hemochromatosis.
    Kershisnik MM; Knisely AS; Sun CC; Andrews JM; Wittwer CT
    Hum Pathol; 1992 Sep; 23(9):1075-80. PubMed ID: 1325409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.